Intellia Therapeutics (NTLA) Return on Sales (2015 - 2026)
Intellia Therapeutics (NTLA) posted quarterly Return on Sales of 0.13% for Q1 2026, up 3.0% year-over-year from 0.12% in Q1 2025, and down 218.51% quarter-over-quarter from 0.04% in Q4 2025.
Intellia Therapeutics (NTLA) Return on Sales (2015 - 2026) Analysis & Trends
Intellia Therapeutics (NTLA) has reported Return on Sales for 12 consecutive years, with 0.13% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales rose 3.0% year-over-year to 0.13%; the TTM figure through Mar 2026 stood at 0.09% (up 5.0% YoY), while the FY2025 annual figure was 0.2%, up 2.0% from the prior year.
- Return on Sales fell to 0.13% in Q1 2026 per NTLA's latest filing, from 0.04% in the prior quarter.
- Across five years, Return on Sales topped out at 0.85% in Q4 2023 and bottomed at 0.41% in Q4 2022.
- Historically, Return on Sales has averaged 0.1% across 5 years, with a median of 0.14% in 2023.
- Annual changes were most pronounced in 2022 — Return on Sales surged 145 bps — and 2024, when it sank 95 bps.
- Intellia Therapeutics' Return on Sales stood at 0.41% in 2022, then jumped by 307 bps to 0.85% in 2023, then tumbled by 112 bps to 0.1% in 2024, then surged by 59 bps to 0.04% in 2025, then plunged by 219 bps to 0.13% in 2026.
- Business Quant data shows NTLA's Return on Sales at 0.13% in Q1 2026, 0.04% in Q4 2025, and 0.16% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Intellia Therapeutics | 1.67 Bn | 1.67 Bn | - | -0.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.25% |
| Mar 31, 2026 | -0.13% |
| Dec 31, 2025 | -0.04% |
| Sep 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.08% |
| Mar 31, 2025 | -0.15% |
| Dec 31, 2024 | -0.10% |
| Sep 30, 2024 | -0.16% |
| Jun 30, 2024 | -0.20% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | 0.85% |
| Sep 30, 2023 | -0.13% |
| Jun 30, 2023 | -0.14% |
| Mar 31, 2023 | -0.13% |
| Dec 31, 2022 | -0.41% |
| Sep 30, 2022 | -0.17% |
| Jun 30, 2022 | -0.15% |
| Mar 31, 2022 | -0.31% |
| Dec 31, 2021 | -0.30% |
| Sep 30, 2021 | -0.93% |